CSF3 and myocardial infarction: Combining granulocyte colony-stimulating factor with a dipeptidylpeptidase-IV (DPP-IV) inhibitor can promote mobilization and migration of recipient bone marrow−derived hematopoietic stem cells into ischemically injured areas, resulting in tissue regeneration after acute myocardial infarction [37].